Search

Your search keyword '"*NEUROFIBROMATOSIS 2"' showing total 3,300 results

Search Constraints

Start Over You searched for: Descriptor "*NEUROFIBROMATOSIS 2" Remove constraint Descriptor: "*NEUROFIBROMATOSIS 2"
3,300 results on '"*NEUROFIBROMATOSIS 2"'

Search Results

5. Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.

6. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.

12. Long-term analysis of ABI auditory performance in patients with neurofibromatosis type 2-related schwannomatosis.

13. TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma.

14. Vestibulární schwannom.

15. Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.

16. Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis.

17. Study of Aspirin in Patients With Vestibular Schwannoma

18. A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion.

19. Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.

20. Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2.

21. Hearing Function after CyberKnife for Vestibular Schwannoma: A Systematic Review.

22. Sporadic pediatric vestibular schwannoma: a case report in a 4-year-old boy.

23. Diagnostic and therapeutic process of neurofibromatosis type 1 and type 2.

24. Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.

25. G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells.

26. NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.

27. First Clinical Experience with a New Device for the Removal of Cochlear Schwannomas.

28. Audiological Outcome of the Simultaneous Tumor Resection and Cochlear Implantation in Two Cases of Sporadic and Two Cases of Neurofibromatosis Type 2-Associated Intracochlear Schwannoma.

29. Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis.

30. Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis.

31. Case of an Intramedullary Ancient Schwannoma of the Brainstem Mimicking Astrocytoma: A Rare Clinical Presentation with a Diagnostic Dilemma.

32. PD‐L1 regulates tumor proliferation and T‐cell function in NF2‐associated meningiomas.

33. Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.

34. Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations.

35. Cases of Mixed Schwannoma–Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.

38. Spinal Miscellaneous Lesions

40. Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.

41. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma

42. Bevacizumab Treatment for Patients with NF2 -Related Schwannomatosis: A Single Center Experience.

43. Navigating Uncharted Waters: Comparative Analysis of Clinical Progression and Outcomes in Vestibular Schwannoma Patients with Papilledema and without Hydrocephalus, Versus Those without Papilledema and Hydrocephalus: A Comprehensive Institutional Insight.

44. Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas.

45. Multiple Cranial Nerve Involvement in a Complex Case of MISME Syndrome in a Paediatric Patient: A Case Report.

46. Atypical teratoid/rhabdoid tumour‐TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition.

47. Is a “floater” always a floater? Case report and short review of sphenoid meningiomas’ ocular manifestation.

48. Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2.

49. Sporadic vestibular schwannoma in a pediatric population: a case series.

50. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.

Catalog

Books, media, physical & digital resources